|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
�����,��ɫ |
|
��Ĥ |
|
�������� |
| ��������������� | |
|
�ǽ��� |
|
�ź� |
| PubMed | |
|
Article by |
|
Article by |
�����������Ĥ��ҩ����Բߵ�ʵ���о���չ
�ǽ���, �ź�
���ϴ�ѧ������һҽԺƤ���� ���� 510632
�����������Ĥ������ڵ�����ɢ����״̬�İ���������Ե���һ�ְ���������ص�������ʽ,����������Եı����ǶԶ��ִ�ͳ�����ҩ��߶���ҩ�������������Ĥ�Ľṹ����ҩ���Ƽ�Ӧ������ҩ��ʵ���о���һ������
[2] Chandra J, Kuhn DM, Mukherjee PK, et al. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol, 2001, 183:5385-5394.
[3] Hawser SP, Douglas LJ. Resistance of Candida albicans biofilms to antifungal agents in vitro. Antimicrob Agents Chemother, 1995, 39:2128-2131.
[4] Chandra J, Mukherjee PK, Leidich SD, et al. Antifungal resistance of Candidal biofilms formed on denture acrylic in vitro. J Dent Res, 2001, 80:903-908.
[5] Lamfon H, Porter SR, McCullough M, et al. Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor to chlorhexidine, fluconazole and miconazole: a longitudinal study. J Antimicrob Chemother, 2004, 53:383-385.
[6] Baillie GS, Douglas LJ. Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents. Antimicrob Agents Chemother, 1998, 42:1900-1905.
[7] Baillie GS, Douglas LJ. Role of dimorphism in the development of Candida albicans biofilms. J Med Microbiol, 1999, 48:671-679.
[8] Ramage G, Bachmann S, Patterson TF, et al. Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J Antimicrob Chemother, 2002,49:973-980.
[9] Baillie GS, Douglas LJ. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J Antimicrob Chemother, 2000, 46:397-403.
[10] Morschhauser J. The genetic basis of fluconazole resistance development in Candida albicans.Biochim Biophys Acta, 2002, 1587:240-248.
[11] Mukherjee PK, Chandra J, Kuhn DM,et al. Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols. Infect Immun, 2003, 71:4333-4340.
[12] Alem MA, Douglas LJ. Effects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans. Antimicrob Agents Chemother, 2004,48:41-47.
[13] Bachmann SP, VandeWalle K, Ramage G,et al. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother, 2002, 46:3591-3596.
[14] Soustre J, Rodier MH, Imbert-Bouyer S,et al. Caspofungin modulates in vitro adherence of Candida albicans to plastic coated with extracellular matrix proteins. J Antimicrob Chemother, 2004, 53:522-525.
[15] Kuhn DM, George T, Chandra J, et al. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother, 2002, 46:1773-1780.